PENTAX Medical announces commitment to work with FDA on tackling scope infection issues

PENTAX Medical has reiterated its commitment to working with the FDA to address infection risk associated with duodenoscopes. 

Advertisement

PENTAX is working with the FDA and professional organizations such as the American Society of Gastrointestinal Endoscopy and the American Gastroenterological Association.

“Working with the FDA to resolve this health issue is our highest priority,” said Mark Koppel, CMO of PENTAX Medical Americas.

More articles on gastroenterology:
Getting down to business: 4 gastroenterologists on learning the other side of medicine
Virginia Mason joins lawsuit against Olympus America – 5 key notes
Dr. David Bernstein named PAION medical advisor

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.